Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery

March 29, 2023 updated by: Wendell Scott

A Comparison of Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery

This study will compare two methods of vacuum (peristaltic or venturi) commonly used during the removal of a femtosecond treated cataract. The investigators will observe which method uses less energy, is gentler on the eye, reduces corneal swelling and if the vision recovers faster with one method compared to the other.

Study Overview

Status

Completed

Conditions

Detailed Description

This is an open, prospective, randomized study to evaluate efficiency and outcomes of femtosecond laser cataract surgery with phacoemulsification performed with one of two standard vacuum systems.

It is estimated that the duration of study participation will be up to 24 months.

There will be randomization to 1 of 2 groups. Both eyes of each subject will be enrolled in the study. The first eye will be randomized to either the Venturi or peristaltic-based vacuum pump. The second eye will then receive the other type of vacuum pump for that procedure.

Study Phases:

Pre-operative Visit Procedure Post-operative Follow up The subject will be seen 1 day, 5-10 days, and 90 days following the procedure.

Surgical Procedure

  • The cataract removal procedure will be performed under sterile technique and according to standard procedures. The femtosecond laser treatment will be followed by phacoemulsification removal of the cataract and implantation of an intraocular lens.
  • Peri-operatively, subjects will be treated with a regimen of antibiotic, steroid and nonsteroidal anti-inflammatory eye drops per standard of care.
  • All surgeries will be performed by the same experienced surgeon/principal investigator using the Catalys® SYSTEM femtosecond laser platform and WHITESTAR SIGNATURE® PRO Phacoemulsification System.
  • Phacoemulsification Settings:

    • For Venturi pump: 600 mmHg vacuum
    • For Peristaltic-based pump: 600 mmHg vacuum and aspiration flow of 50 mL/min
    • Other settings: ultrasound energy application parameters will be the same for the two groups

Study Procedures

  • The study will include routine cataract pre-operative testing with Nidek OPD, Galilei G4, and IOLMaster, and repeated at the post-op visits. An endothelial cell count of the cornea will be performed at the pre-operative visit and at the 90 day follow up visit.
  • Subjects will be randomized to phacoemulsification settings of Venturi vacuum of 600 mmHg or peristaltic vacuum of 600 mmHg and aspiration flow of 50 mL/min. All other phacoemulsification settings will be identical. The laser settings will be based on the grade of cataract only and will not be altered for this study.
  • The phacoemulsification time, energy Ellips FX EFX, and average phacoemulsification energy will be recorded. The laser procedure time and total procedure time will be recorded. Complications will be recorded. Additional patient characteristics will also be recorded.
  • Pre-Operative Visit:

    • Nidek Refractive Power/Corneal Analyzer OPD-Scan, Galilei G4 Corneal Topography, IOLMaster 700 keratometry (standard of care)
    • Complete eye examination (standard of care)
    • Brightness Acuity Test (BAT) (standard of care)
    • Review and confirm eligibility (research)
    • Informed Consent for study (research)
    • Randomization (research)
    • Endothelial Cell Count (research)
    • Medical Record Review (research)
  • Surgical Procedure (Day 0) (standard of care)

    • Medical Record Review (research)
    • Adverse Event Assessment (research)
  • Post-operative Visit 1 (Day 1):

    • Eye exam to include uncorrected and pinhole visual acuity, Intraocular pressure (IOP) and slit-lamp exam (standard of care)
    • Galilei G4 Corneal Topography, IOLMaster 700 keratometry (standard of care)
    • Medical Record Review (research)
    • Adverse Event Assessment (research)
  • Post-operative Visit 2 (Day 5-10):

    • Eye exam to include uncorrected and best corrected visual acuity, Pinhole visual acuity, IOP, and slit-lamp exam (standard of care)
    • Nidek Refractive Power/Corneal Analyzer OPD-Scan, Galilei G4 Corneal Topography, IOLMaster 700 keratometry (standard of care)
    • Medical Record Review (research)
    • Adverse Event Assessment (research)
  • Post-operative Visit 3 (Day 60-90 days):

    • Eye exam to include uncorrected and best corrected visual acuity, Pinhole visual acuity, IOP, and slit-lamp exam (research)
    • Nidek Refractive Power/Corneal Analyzer OPD-Scan, Galilei G4 Corneal Topography, IOLMaster 700 keratometry (research)
    • Endothelial Cell Count (research)
    • Medical Record Review (research)
    • Adverse Event Assessment (research)
  • Unscheduled Visit:

    • A medical record review and an adverse event assessment will be performed at any unscheduled visit.
    • Additional evaluations will be completed at the discretion of the Principal Investigator based on the subject's presenting complaint.

Statistical Analysis

Sample Size and Power:

· The study aims to enroll 250 study subjects for a total of 500 eyes with bilateral grade 1-3 nuclear sclerotic cataracts who will be undergoing planned femtosecond laser cataract surgery.

Statistical Methods:

· The statistical analysis plan will include use of descriptive statistics and statistical tests including unpaired t-tests.

Study Type

Observational

Enrollment (Actual)

111

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Springfield, Missouri, United States, 65804
        • Mercy Clinic Eye Specialists

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  • The study aims to enroll 250 study subjects for a total of 500 eyes with bilateral grade 1-3 nuclear sclerotic cataracts who will be undergoing planned femtosecond laser cataract surgery.
  • The study will include adults undergoing femtosecond laser cataract surgery with grade 1-3 nuclear sclerotic cataracts.

Description

Inclusion Criteria:

  • Males and females ages 22-90 yrs
  • Diagnosis of senile cataract
  • Grade 1-3 Nuclear sclerosis
  • Cataract removal required for both eyes
  • Scheduled for femtosecond laser cataract surgery at Mercy Surgery Center or Mercy National Eye Center in Springfield, MO

Exclusion Criteria:

  • Diagnosis of Fuch's dystrophy
  • Presence of cornea scars
  • Planned laser astigmatism treatment
  • Diagnosis of pseudoexfoliation
  • History of direct ocular trauma with secondary iris or lens trauma
  • Presence of grade 4 cataracts
  • History of previous eye surgery
  • Severe glaucoma or retina disease impairing vision
  • Planned surgery that is will be combined with other surgical eye procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Venturi pump
This cohort will receive femtosecond laser cataract surgery with Venturi pump.
The venturi pump makes use of the venturi effect to create a vacuum. The venturi effect creates a vacuum by the flow of a fluid, typically air, over an opening. In many phacoemulsification machines, this requires nitrogen tanks or a self-contained air compressor. The vacuum level is created within a rigid drainage cassette, to which the phaco aspiration tubing is connected. Since there is no milking of the aspiration line, the phaco tubing can be made rigid with low compliance.
Peristaltic vacuum pump
This cohort will receive femtosecond laser cataract surgery with peristaltic pump.
The peristaltic pump uses rollers to compress the phacoemulsification outflow tubing in a peristaltic manner, thereby creating flow and vacuum. The compression of the rollers on the tubing with the rotation of the pump physically moves fluid and creates a continuous "milking" action on the fluid column, The phaco machine can directly control this flow level, hence the term flow based, however, the preset vacuum level is only achieved once there is occlusion of the outflow line, typically at the phaco needle tip with cataract material.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phacoemulsification energy required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
Phaco EFX (the effective phaco time with a specific coefficient for the transversal movement of the phaco tip- expressed in seconds.)
Intraoperative Visit
Duration of ultrasound time required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
Total ultrasound time - measured in seconds
Intraoperative Visit
Phacoemulsification power required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
Average power - measured in percentage
Intraoperative Visit
Duration of microscope time required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
Microscope time - measured in seconds intraoperatively
Intraoperative Visit
Duration of laser time required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
Laser time - measured in seconds intraoperatively
Intraoperative Visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Uncorrected visual acuity among subjects who underwent femtosecond laser cataract surgery procedure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
1) Uncorrected Visual Acuity using the Snellen Eye Chart
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Best Corrected Visual Acuity among subjects who underwent femtosecond laser cataract surgery procedure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Best Corrected Visual Acuity using the Snellen Eye Chart
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Pinhole Visual Acuity among subjects who underwent femtosecond laser cataract surgery procedure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Pinhole visual acuity using pinhole technique and the Snellen eye chart
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Presence of corneal edema as assessed by intra-ocular pressure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Measured in mmHg using an applanation tonometer
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Presence of corneal edema as assessed by slit lamp examination
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
The examiner will use a slit lamp microscope to evaluate the eye structures and intra-ocular pressure
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Measure of the corneal endothelium
Time Frame: This test will be done Pre-operatively and Post op 60-90 day visit
Endothelial Cell Count will be evaluated by Konan Specular Microscopy
This test will be done Pre-operatively and Post op 60-90 day visit
Central corneal thickness as measured by IOLMaster Biometry
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
IOL Master Biometry directly measures the corneal thickness by OCT
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Central corneal thickness as measured by Galilei G4 Biometry
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
Galilei G4 measures central corneal thickness
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse Events
Time Frame: 90 days
Adverse Events will be recorded an monitored for each group and compared.
90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Wendell J Scott, MD, Mercy Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2019

Primary Completion (Actual)

March 16, 2023

Study Completion (Actual)

March 29, 2023

Study Registration Dates

First Submitted

May 24, 2019

First Submitted That Met QC Criteria

May 29, 2019

First Posted (Actual)

May 31, 2019

Study Record Updates

Last Update Posted (Actual)

April 3, 2023

Last Update Submitted That Met QC Criteria

March 29, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 19-082

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract Senile

Clinical Trials on Venturi pump

Subscribe